Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ORDENES-CAVIERES, GONZALO |
| Género | Hombre |
| Área Principal WOS | Medicine, General & Internal; |
| Afiliación Principal | Pontificia Universidad Católica De Chile |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, General & Internal | 1 |
| Scopus | #Pub |
|---|---|
| Medicine (All) | 4 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 1 |
| Autor | Género | # Pub |
|---|---|---|
| PIMENTEL, EDUARDO | Hombre | 1 |
| RETAMAL, JOSE | Hombre | 1 |
| GRAU-DIEZ, ARTURO | Hombre | 1 |
| ANDINO-NAVARRETE, ROMINA | Mujer | 1 |
| CORIA, MARCELO | Hombre | 1 |
| SCHMIDT, JIMENA | Mujer | 1 |
| IBANEZ-BRURON, MARIA CAROLINA | Mujer | 1 |
| CRUZAT, ANDREA | Mujer | 1 |
| Institución | # Pub |
|---|---|
| Pontificia Universidad Católica De Chile | 4 |
| Proyecto Epistemonikos | 2 |
| Proyecto Epistemon | 1 |
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Aqueous Shunt Versus Trabeculectomy For Treatment Of Glaucoma | 2018 | 2 | artículo de investigación | Medwave | WoS Scopus |
| Natamycin Versus Voriconazole For Fungal Keratitis | 2018 | 2 | artículo de investigación | Medwave | WoS Scopus |
| Secukinumab For Plaque Psoriasis | 2018 | 1 | artículo de investigación | Medwave | WoS Scopus |
| Accuracy Of Artificial Intelligence Compared To Trained Medical Technologists In Diabetic Retinopathy Screening | 2021 | 0 | artículo de investigación | Revista Médica De Chile | WoS SciELO Scopus |
| Palabra Clave | #Pub |
|---|---|
| grade | 3 |
| epistemonikos | 3 |
| secukinumab | 1 |
| plaque psoriasis | 1 |
| prevalence | 1 |
| primary-care | 1 |
| program | 1 |
| public health | 1 |
| regimen | 1 |
| safety | 1 |
| natamycin | 1 |
| subanalysis | 1 |
| telemedicine | 1 |
| trabeculectomy | 1 |
| treatment outcomes | 1 |
| tube | 1 |
| tvt | 1 |
| valve implant | 1 |
| voriconazole | 1 |
| phase-ii | 1 |
| ahmed glaucoma | 1 |
| moderate | 1 |
| metaanalysis | 1 |
| mass screening | 1 |
| fungal keratitis | 1 |
| efficacy | 1 |
| double-blind | 1 |
| diabetic retinopathy | 1 |
| coverage | 1 |
| controlled-trial | 1 |
| complications | 1 |
| biological treatments | 1 |
| biologic therapies | 1 |
| artificial intelligence | 1 |
| aqueous shunt | 1 |